NCT01366573View on ClinicalTrials.gov

GSK1521498 Alcohol Interaction Study

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 13, 2011

Primary Completion Date

September 16, 2011

Study Completion Date

September 16, 2011

Conditions
Alcoholism
Interventions
DRUG

GSK1521498

GSK1521498 20 mg administered with alcohol to determine PK/PD interactions

OTHER

Placebo

Placebo

Trial Locations (1)

78744

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
collaborator

University of Cambridge

OTHER

lead

GlaxoSmithKline

INDUSTRY

NCT01366573 - GSK1521498 Alcohol Interaction Study | Biotech Hunter | Biotech Hunter